2,055
Participants
Start Date
May 31, 2013
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
Mammalian cell based flu vaccine
Egg based flu vaccine
253, Novartis Investigational Site, Manila
252, Novartis Investigation Site, Manila
250, Novartis Investigational Site, City of Muntinlupa
251, Novartis Investigational Site, City of Muntinlupa
254, Novartis Investigational Site, City of Muntinlupa
100, Novartis Investigational Site, Westmead
103, Novartis Investigational Site, Carlton
108, Novartis Investigational Site, Auchenflower
107, Novartis Investigational Site, Sherwood
104, Novartis Investigational Site, North Adelaide
105, Novartis Investigational Site, Subiaco
150, Novartis Investigational Site, Beckenham
200, Novartis Investigational Site, Bangkok
202, Novartis Investigational Site, Bangkoknoi
308, Novartis Investigational Site, Winston-Salem
319, Novartis Investigational Site, Mt. Pleasant
312, Novartis Investigational Site, Ponte Vedra
320, Novartis Investigational Site, Mobile
318, Novartis Investigational Site, Nashville
310, Novartis Investigational Site, Bristol
201, Novartis Investigational Site, Khon Kaen
317, Novartis Investigational Site, Cleveland
313, Novartis Investigational Site, Augusta
305, Novartis Investigational Site, Newton
302, Novartis Investigational Site, Wichita
301, Novartis Investigational Site, Wichita
311, Novartis Investigational Site, Fremont
309, Novartis Investigational Site, Tulsa
303, Novartis Investigational Site, South Jordan
304, Novartis Investigational Site, Salt Lake City
306, Novartis Investigational Site, Salt Lake City
315, Novartis Investigational Site, Salt Lake City
314, Novartis Investigational Site, Warwick
151, Novartis Investigational Site, Takapuna
Lead Sponsor
Novartis Vaccines
INDUSTRY